Mumps Vaccines

//Mumps Vaccines
­

Dangerously Shifting Demographics

From 1967 to 1971, only 8% of mumps cases occurred in people under 14 years of age. By 1987, after the mumps vaccination campaigns, over 38% were occurring in over the 14 population. The mumps vaccine has pushed the disease into older age groups, who experiencemore serious complications from the disease.

Adverse Effects

The mumps vaccine is well-documented to have caused anaphylaxis, aseptic meningitis, diabetes, encephalitis, mumps, orchitis, and death. In 1993, Japan removed mumps vaccine from the market because it was reported to have causes aseptic meningitis in 1 out of every 1044 vaccinees.

Review the documentation on this page to verify the risks of injecting this vaccine in all it’s forms.

Mumps is relatively harmless

When experienced in childhood, mumps is a mild experience, but it can be much more severe in older teenagers and adults. But even the complication in older populations like orchitis, ovitis, and hearing loss are usually temporary. Permanent afflictions and death are very rare.

Mumps is a Good Thing to Acquire

Several studies show that acquiring mumps in childhood reduces the likelihood of more serious adult diseases, like ovarian cancer. That’s why 180 European doctors stated that “there is no plausible medical reason… to immunize girls against mumps.

Mumps Outbreaks Occur in Highly Vaccinated Populations

In 1981, 94% of all mumps cases occurred in vaccinated, Massachusetts children. In 1987, 87% of mumps cases occurred in a Minnesota outbreak. In 1991, 67 of 68 cases of mumps occurred in a Tennessee outbreak. There are many more such examples.

 

Mumps Vaccines by Brand

M-M-Vax Measles and Mumps Virus Vaccine Live
Manufacturer Merck
Microorganism Measles, Mumps
Licensed 06/02/1998
Recommendations 12 months or older, single dose.
Ingredients Gelatin, Neomycin, Sorbitol, Sodium chloride, Bovine (cow) serum, Sodium phosphate, Virus: Measles, Virus: Mumps, Human albumin
Product Descriptions Package insert

M-M-RVAXPRO Measles, mumps, and rubella vaccine (live)
Manufacturer Merck Sharp & Dohme B.V.
Microorganism Measles, Mumps, Rubella
Licensed 05/05/2006
Recommendations Individuals 12 months or older should receive one injection. A second injection may be given at least 4 weeks after the first. The second is intended for peoples who did not respond to the first injection for any reason. There is no information on the safety and effectiveness of this product on infants below 12 months.
Ingredients Gelatin, Monosodium Glutamate (MSG), Neomycin, Phenol, Sorbitol, Sodium bicarbonate, Sucrose, Sodium phosphate, Sodium hydroxide, Hydrochloric acid, Medium 199, Potassium phosphate, Virus: Measles, Virus: Mumps, Virus: Rubella, Minimum Essential Medium
Product Descriptions

MMR® II Measles, Mumps, and Rubella Virus Vaccine Live
Manufacturer Merck & Co.
Microorganism Measles, Mumps, Rubella
Licensed 12/29/2006
Recommendations M-M-R II is indicated for simultaneous immunisation against measles, mumps, and rubella in persons 12 to 15 months of age or older. A second s.c. injection of M-M-R II or monovalent measles vaccine is recommended.
Ingredients Gelatin, Neomycin, Sorbitol, Sucrose, Sodium chloride, Bovine (cow) serum, Sodium phosphate, Virus: Measles, Virus: Mumps, Virus: Rubella, Egg protein, Human albumin
Product Descriptions

Mumpsvax® Monovalent Mumps
Manufacturer Merck
Microorganism Measles, Mumps, Rubella
Licensed 12/28/1967 Discontinued – Mumpsvax. Mumps Virus Vaccine, live attenuated. 2004
Recommendations
Ingredients Gelatin, Human Diploid cells: MRC5 proteins, Neomycin, Sorbitol, Sucrose, Sodium chloride, Bovine (cow) serum, Sodium phosphate, Virus: Mumps, Egg protein
Product Descriptions Vaccine safety

Priorix® Combined measles, mumps and rubella vaccine, live, attenuated
Manufacturer GlaxoSmithKline
Microorganism measles, mumps and rubella
Licensed 11/25/1997
Recommendations Single injection at 12 months of age with booster recommended at 4-6 years of age.
Ingredients Human Diploid cells: MRC5 proteins, Sorbitol, Virus: Measles, Virus: Mumps, Virus: Rubella, Chick embryo cells, Lactose, Mannitol, Amino acids, Human albumin, Neomycin sulphate
Product Descriptions

ProQuad® Measles-Mumps-Rubella-Varicella Virus Vaccine Live, MMRV
Manufacturer Merck & Co.
Microorganism Measles, Mumps, Rubella, Varicella
Licensed 02/27/2007 – suspended production 03.22.2007
Recommendations Indicated for use in children 12 months to 12 years of age. You must wait at least 1 month between getting a regular MMR vaccine and ProQuad. ProQuad may be given at the same time as the Hib and HepB vaccines. ProQuad may be used as the first dose of MMR and Varivax. ProQuad may be used as the second dose of MMR, if the child also needs a chicken pox shot.
Ingredients Gelatin, Monosodium Glutamate (MSG), Human Diploid cells: MRC5 proteins, Neomycin, Sorbitol, Sodium bicarbonate, Sucrose, Sodium chloride, Sodium phosphate-dibasic dodecahydrate, Bovine (cow) serum, Potassium phosphate, Virus: Measles, Virus: Mumps, Virus: Rubella, Human diploid cells (WI-38), Chick embryo cells, Potassium chloride, Virus: Varicella (chickenpox), Human albumin
Product Descriptions